A therapy management contract shall apply only to conditions for which protocols have been agreed to by an authorized prescriber and a licensed pharmacist in accordance with the regulations adopted under this subtitle. A therapy management contract shall include: A statement that none of the parties involved in the therapy management contract have been coerced, given economic incentives, excluding normal reimbursement for services rendered, or involuntarily required to participate; Notice to the patient indicating: That the patient may terminate the therapy management contract at any time; and The procedure by which the patient may terminate the therapy management contract; A procedure for periodic review by the authorized prescriber, of the drugs modified pursuant to the agreement or changed with the consent of the authorized prescriber; and Reference to a protocol, which will be provided to the patient on request. A therapy management contract may be entered into in writing or orally. If a therapy management contract is entered into orally, the parties to the therapy management contract shall reduce the agreement to writing within 30 days after entering into the therapy management contract. A therapy management contract may be in electronic form. Any party to the therapy management contract may terminate the contract at any time. The Board may assess a fee, as established in regulation, for approval of a pharmacist to enter into a prescriber–pharmacist agreement.